Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in various connective tissues, synovial fluid, and the vitreous humor of the eye. It acts as a lubricant and shock absorber. Synthetic HA is used therapeutically.
## Primary Indications
* **Intra-articular injection:** Osteoarthritis (particularly knee pain).
* **Ophthalmic surgery:** Viscoelastic agent to maintain space during cataract and other intraocular surgeries.
* **Wound healing:** Topical formulations for chronic wounds.
* **Dermal fillers:** Aesthetic correction of wrinkles and folds.
## Adult Dosing
* **Intra-articular (e.g., Synvisc, Euflexxa, Durolane):** Dosing varies by product.
* Typically, a single intra-articular injection is given.
* Some products may require a series of injections (e.g., 3-5 weekly injections).
* Maximum frequency and number of treatments per joint are product-specific and often limited to once or twice a year. Consult specific product labeling or local guidelines.
* **Ophthalmic (e.g., Healon, Viscoat):** 0.25 mL to 2 mL per procedure, depending on the surgical site and requirement.
* **Topical (wound care):** Apply as directed by product labeling, typically once or twice daily.
* **Dermal fillers:** Administered by trained professionals. Volumes depend on the area treated and desired aesthetic outcome.
## Pediatric Dosing
Established pediatric dosing for intra-articular or ophthalmic use is generally not available. Use in pediatric populations should be based on specialist recommendations and available literature, with caution.
## Dose Adjustments
No specific dose adjustments are typically required for hepatic or renal impairment due to the localized administration and minimal systemic absorption for intra-articular and ophthalmic preparations.
## Contraindications
* Known hypersensitivity to hyaluronic acid or any component of the formulation.
* Infection at or near the injection site.
* Skin infection in the area of intended injection.
* Intra-articular use: Known bleeding disorders or concurrent anticoagulant therapy may increase the risk of local hematoma.
## Adverse Effects
* **Intra-articular:** Local pain, swelling, stiffness, redness, warmth at the injection site. Transient joint effusion. Rare: Allergic reactions, infection.
* **Ophthalmic:** Transient intraocular pressure elevation, inflammation, corneal edema.
* **Topical:** Skin irritation, redness.
* **Dermal fillers:** Bruising, swelling, redness, pain, itching, nodules, infection, vascular occlusion (rare but serious).
## Key Drug Interactions
* **Intra-articular:** Concurrent use with other intra-articular injections (e.g., corticosteroids) may require careful timing and consideration of potential additive effects or altered efficacy. Data is limited.
* **Ophthalmic:** May interfere with certain diagnostic tests or intraocular lenses.
## Monitoring
* **Intra-articular:** Monitor for signs of infection or significant adverse reactions at the injection site. Assess pain and functional improvement.
* **Ophthalmic:** Monitor intraocular pressure post-procedure.
* **Topical:** Monitor wound healing and for signs of local irritation.
* **Dermal fillers:** Monitor for any delayed adverse events.
## Clinical Pearls
* Hyaluronic acid for osteoarthritis is generally considered an adjunct therapy, not a cure. Efficacy and duration of relief can vary significantly between individuals and products.
* Proper aseptic technique is crucial for intra-articular and ophthalmic injections to minimize the risk of infection.
* For intra-articular injections, avoid strenuous activity for 24-48 hours post-injection.
* Topical HA can help maintain a moist wound environment conducive to healing.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information, clinical guidelines, and institutional protocols before administering any medication. Product formulations and recommendations can vary.
